Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • RegulatoryPress Releases

Sickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations

  • The Pharma Data
  • July 5, 2025

Global Sickle Cell Disease Treatment Market Poised for Robust Growth Through 2035 The global sickle cell disease (SCD) treatment market is set to witness substantial growth from 2025 to 2035,…

Read MoreSickle Cell Disease Treatment Market Outlook 2025–2035: R&D, Patents, Pipeline & Regulations
  • Press Releases

Cancer Vaccine Market 2021–2031: Growth Driven by Innovation & Precision Immunotherapy

  • The Pharma Data
  • July 5, 2025

Global Cancer Vaccine Market Poised for Strong Growth Through 2031, Driven by Innovation in Precision Immunotherapy and Personalized Medicine The global cancer vaccine market has experienced robust growth over recent…

Read MoreCancer Vaccine Market 2021–2031: Growth Driven by Innovation & Precision Immunotherapy
  • Press Releases

Pharma & Biotech Distribution Deals Report 2025: Company A–Z Directory & Trends

  • The Pharma Data
  • July 5, 2025

In-Depth Report Sheds Light on Distribution Deals in the Pharma and Biotech Sectors (2020–2025) A newly updated research publication, Distribution Deals in Pharmaceuticals and Biotechnology, offers a comprehensive analysis of…

Read MorePharma & Biotech Distribution Deals Report 2025: Company A–Z Directory & Trends
  • Business

Pharma & Biotech Manufacturing Agreement Trends 2020–2025

  • The Pharma Data
  • July 5, 2025

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology (2020–2025): An In-Depth Analysis of Industry Trends, Financials, and Strategic Partnerships new industry report titled “Manufacturing and Supply Deals in Pharmaceuticals and…

Read MorePharma & Biotech Manufacturing Agreement Trends 2020–2025
  • BusinessNews

WHO Welcomes IMF Support for Jordan’s Pandemic Preparedness

  • The Pharma Data
  • July 5, 2025

WHO Applauds IMF’s Landmark $700 Million Support to Jordan for Pandemic Preparedness and Response The World Health Organization (WHO) has lauded a groundbreaking decision by the International Monetary Fund (IMF)…

Read MoreWHO Welcomes IMF Support for Jordan’s Pandemic Preparedness
  • ResearchPress Releases

Gamma Delta T Cell Therapy Market Outlook 2031: U.S. & China Lead Clinical Trials

  • The Pharma Data
  • July 4, 2025

Gamma Delta T Cell Therapy: A Transformative Frontier in Cancer Immunotherapy with U.S. and China Leading Global Trials Gamma delta (γδ) T cell therapy is rapidly emerging as a promising…

Read MoreGamma Delta T Cell Therapy Market Outlook 2031: U.S. & China Lead Clinical Trials
  • Press Releases

Acadia Pharma Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

  • The Pharma Data
  • July 4, 2025

Acadia Pharmaceuticals Grants Equity Awards to New Hires Under Nasdaq Rule 5635(c)(4) Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to…

Read MoreAcadia Pharma Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
  • ResearchPress Releases

Manitoba Bioscience Association Applauds Government Support for Research and Trials

  • The Pharma Data
  • July 4, 2025

Manitoba Bioscience Association Backs Government Plan to Boost Research and Clinical Trials Bioscience Association Manitoba (BAM) has voiced strong support for a major new initiative from the Manitoba government aimed…

Read MoreManitoba Bioscience Association Applauds Government Support for Research and Trials
  • Business

ISS Backs Glass Lewis in Supporting SINOVAC’s Current Board

  • The Pharma Data
  • July 4, 2025

ISS Backs Glass Lewis in Supporting SINOVAC’s Current Board, Rejects Former Slate Ahead of Special Meeting SINOVAC Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced…

Read MoreISS Backs Glass Lewis in Supporting SINOVAC’s Current Board
  • Regulatory

InnoCare’s ADC ICP-B794 Trial Approved in China

  • The Pharma Data
  • July 4, 2025

InnoCare Secures IND Approval in China for B7-H3-Targeted ADC ICP-B794 to Advance Solid Tumor Therapies InnoCare Pharma a leading biopharmaceutical company dedicated to developing innovative treatments for cancer and autoimmune…

Read MoreInnoCare’s ADC ICP-B794 Trial Approved in China
  • Regulatory

Biotech Leaders, Investors Urge FDA to Keep Mifepristone Access

  • The Pharma Data
  • July 4, 2025

Biotech Executives and Investors Urge FDA to Preserve Access to Mifepristone Amid Legal Uncertainty A group of leading biotechnology executives, investors, and scientific experts are urging the U.S. Food and…

Read MoreBiotech Leaders, Investors Urge FDA to Keep Mifepristone Access
  • Regulatory

Regeneron Wins FDA Nod for Myeloma Drug, Unlocks $600M Potential

  • The Pharma Data
  • July 4, 2025

Regeneron Secures FDA Accelerated Approval for Lynozyfic in Multiple Myeloma, Eyes Differentiation Despite Market Head Start by Rivals In a bid to strengthen its oncology portfolio, Regeneron Pharmaceuticals announced Wednesday…

Read MoreRegeneron Wins FDA Nod for Myeloma Drug, Unlocks $600M Potential
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • EmeraNova™ Strengthens Innovation Leadership with Launch of New Accelerator ProgramNovember 5, 2026
  • Global Healthy Living Foundation Highlights Advances in Myositis and Polymyalgia Rheumatica Research at ACR Convergence 2026November 5, 2026
  • Polaris Rx Chosen by Bristol Myers Squibb to Distribute ZENBEXUS™, the First FDA-Approved CELMoD Treatment for Multiple MyelomaNovember 5, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.